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Polychlorinated biphenyls (PCBs) are 
a class of persistent and lipophilic human-
made compounds widely used in industrial 
and consumer products for decades before 
their production was banned in the United 
States and other developed countries in the 
late 1970s. PCBs remain ubiquitous environ-
mental contaminants because of their exten-
sive use and persistence. The half-life of PCBs 
in the blood ranges from < 1 to > 10 years, 
depending on the congener (Brown 1994; 
Phillips et al. 1989b). PCBs can be measured 
in most of the general population because 
of their environmental ubiquity and persis-
tence. For example, in a recent report of a 
large and statistically representative sampling 
of 1,800 individuals ≥ 12 years of age from 
the U.S. population, 31 of 35 PCB congeners 
measured were detected in > 60% of serum 
samples, and 21 congeners were detected in 
> 95% of samples (Patterson et al. 2009). 
The general population is exposed primar-
ily through ingestion of contaminated foods 
(e.g., fish, meat, and dairy products), although 
occupational, ambient, and indoor sources of 
exposure may exist as well (Freels et al. 2007; 
Harrad et al. 2006, 2009; Herrick 2010; 
Herrick et al. 2004, 2007; Kohler et al. 2005; 
Norstrom et al. 2010; Wingfors et al. 2006).
Exposure to PCBs can result in an inter-
nal dose to the female reproductive tract, as 
PCBs have been measured in human follicu-
lar fluid (De Felip et al. 2004; Meeker et al. 
2009; Younglai et al. 2002), ovarian tissue 
(Mes et al. 1990), placenta, uterine muscle, 
and amniotic fluid (Polishuk et al. 1977), as 
well as in embryos and fetuses (Covaci et al. 
2002; Nishimura et al. 1977), providing evi-
dence of exposure to critical tissues during 
important windows of early development. 
PCBs have been associated with a range of 
adverse health effects [Agency for Toxic 
Substances and Disease Registry (ATSDR) 
2000; Carpenter 2006], including adverse 
effects on reproduction (reviewed by Faroon 
et al. 2001; Foster 1995; Kimbrough 1995; 
Lione 1988; Longnecker et al. 1997; Toft 
et al. 2004) and increased risk of pregnancy 
loss (Toft et al. 2010). However, the human 
data available on this topic to date remain 
vague and largely inconclusive. In our study 
we explored the relationship between serum 
PCB concentrations and early pregnancy loss 
among women undergoing in vitro fertiliza-
tion (IVF) and intracytoplasmic sperm injec-
tion (ICSI). This study population serves as 
a unique model to study early pregnancy end 
points not otherwise observable in women.
Methods
Study population. Details of the main 
study within which the present substudy 
was performed have been described previ-
ously (Meeker et al. 2007a, 2007b). Briefly, 
between August 1994 and June 2003, cou-
ples undergoing IVF or ICSI were recruited 
through three Boston-area clinics to partici-
pate in a study of predictors of IVF outcomes. 
The main study was conducted in two phases 
(1994–1998 and 1999–2003) corresponding 
to a 5-year renewal of the study after the com-
pletion of the first 5 years. Study protocols 
were approved by the human research com-
mittees at Brigham and Women´s Hospital, 
Harvard School of Public Health, and the 
University of Michigan. Study subjects gave 
written consent before participating in the 
study. Approximately 65% of couples who 
were approached agreed to participate in the 
study. Most women who declined participa-
tion cited lack of time or did not want the 
added stress of participating. Participation did 
not vary greatly by clinic, and IVF outcomes 
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Ba c k g r o u n d: Human exposure to polychlorinated biphenyls (PCBs) remains widespread. PCBs 
have been associated with adverse reproductive health outcomes including reduced fecundability 
and increased risk of pregnancy loss, although the human data remain largely inconclusive.
oB j e c t i v e: Our goal was to explore the relationship between serum PCB concentrations and early 
pregnancy loss among a large cohort of women undergoing in vitro fertilization (IVF) between 1994 
and 2003.
Me t h o d s : Concentrations of 57 PCB congeners were measured in serum samples collected dur‑
ing 827 IVF/intracytoplasmic sperm injection cycles from 765 women. Joint statistical models that 
accommodate multiple outcomes and multiple cycles per woman were used to assess the relation‑
ship between serum PCB quartiles and implantation failure, chemical pregnancies (human chori‑
onic gonadotropin level > 5.0 mIU/mL) that did not result in clinical pregnancy, or spontaneous 
abortion, while also adjusting for confounders.
re s u l t s: PCB‑153 was the congener present in the highest concentration (median, 46.2 ng/g 
lipid). Increasing quartiles of PCB‑153 and the sum of all measured PCB congeners (∑PCBs) were 
associated with significantly elevated dose‑dependent odds of failed implantation. Adjusted odds 
ratios (95% confidence interval) for highest versus lowest quartile were 2.0 (1.2–3.4) for PCB‑153 
and 1.7 (1.0–2.9) for ∑PCBs. There were suggestive trends for increased odds of implantation fail‑
ure for PCB‑118 and cytochrome P450–inducing congeners (p‑values for trend = 0.06). No statisti‑
cally significant associations between PCBs and chemical pregnancy or spontaneous abortion were 
found.
co n c l u s i o n s: Serum PCB concentrations at levels similar to the U.S. general population were 
associated with failed implantation among women undergoing IVF. These findings may help 
explain previous reports of reduced fecundability among women exposed to PCBs.
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did not differ by participants and nonpartici-
pants. Couples who required donor gametes, 
gestational carrier, or gamete intrafallopian 
transfer were not eligible for enrollment. After 
these exclusions, 2,350 couples were enrolled 
in the main study. Many couples underwent 
multiple IVF/ICSI cycles (up to six), with the 
mean being two cycles per couple.
All IVF outcome variables were defined 
from data abstracted from the medical record 
by trained research nurses. Only women 
who proceeded to embryo transfer were eli-
gible for the present analysis. When at least 
one embryo was transferred but human chori-
onic gonadotropin (hCG) levels did not reach 
5.0 mIU/mL, the cycle outcome was defined as 
a failure of implantation. A chemical pregnancy 
was defined by a luteal hCG measurement of 
≥ 5.0 mIU/mL with no further evidence (ges-
tational sac and fetal heartbeat) of a continued 
pregnancy. Clinical pregnancy was determined 
by ultrasound visualization of a gestational sac 
and a fetal heartbeat. Among clinically rec-
ognized pregnancies, outcomes included in 
the analysis were spontaneous abortion (fetal 
demise before 20 weeks of gestation) and live 
birth of at least one infant. Numbers for the 
outcomes of ectopic pregnancy (gestation 
outside of the uterus), molar pregnancy, and 
stillbirth (fetal demise at 20 gestational weeks 
or later) lacked power to investigate indepen-
dently and were excluded from further consid-
eration in the present analysis.
Because of financial constraints, we were 
unable to measure PCBs in serum from all 
women and cycles in the study. Thus, to 
maximize statistical power we based our sam-
pling strategy on the outcomes of interest 
(i.e., failed implantation, chemical pregnancy, 
and spontaneous abortion) to improve sta-
tistical power. Because failed implantation is 
a common occurrence, we analyzed serum 
PCB concentrations for a random sample 
of 200 women with first-cycle implantation 
failures. Because chemical pregnancies and 
spontaneous abortions were less common, 
all cycles from the entire cohort with these 
outcomes were selected. A corresponding 
sample of first-cycle live births was selected 
using stratified sampling based on age cate-
gory, study center, and study phase. In addi-
tion to these selected women, a random 
sample of 265 repeated cycles among a subset 
of 110 women was selected for PCB analysis 
in a prior analysis of within-woman variability 
in serum PCB concentrations (Meeker et al. 
2009), and outcome data from those cycles 
were also considered in the present analysis. 
In total, 765 women, who underwent a total 
827 IVF/ICSI cycles, were included in the 
present analysis. The 827 cycles comprised 
229 implantation failures, 177 chemical 
pregnancies, 124 spontaneous abortions, and 
297 live births.
Measurement of PCBs in serum. Blood 
samples were collected from women at their 
first IVF/ICSI cycle during the follicular phase 
immediately before hCG administration. Our 
recent longitudinal analysis showed a very 
strong correlation between PCB concentra-
tions measured in blood samples collected 
during different IVF cycles within women 
(Meeker et al. 2009). Thus, only a single blood 
sample from the first cycle of each woman was 
analyzed for PCBs. The serum fraction was 
separated for all blood samples by centrifuga-
tion for 5 min, aliquoted, and stored at –80°C 
until analysis. Measurement of PCBs in serum 
was conducted by the organic chemistry ana-
lytical laboratory, Harvard School of Public 
Health, using methods described previously 
(Hauser et al. 2003; Korrick et al. 2000). In 
brief, after liquid-liquid extraction and column 
chromatography cleanup, the samples were 
analyzed by gas chromatography with dual 
micro-electron capture detection on two capil-
lary columns of different polarity using two 
internal standards. Samples were accompanied 
by the following quality control samples: pro-
cedural blanks, matrix spike samples, and labo-
ratory control samples. Each sample was spiked 
with two surrogate compounds to moni  tor 
the efficiency of the extraction procedure. All 
final results were reported after subtracting 
the amount of the analyte measured in the 
procedural blank associated with the analytic 
batch. Results were not adjusted for surrogate 
recoveries. Target analytes included 57 indi-
vidual PCB congeners. Method detection lim-
its (MDLs) were determined as three times the 
standard deviation obtained from the analysis 
of the eight aliquots of pooled serum fortified 
with target analytes at 0.02 ng/g serum (U.S. 
Environmental Protection Agency 1984). The 
wet-weight MDL values for all PCB congeners 
were < 0.05 ng/g, with most of the congeners 
< 0.01 ng/g.
Because PCBs partition according to the 
lipid content of tissues, and serum lipid levels 
vary between fasting and nonfasting states, 
serum lipids also need to be considered for the 
valid interpretation of serum levels (Phillips 
et al. 1989a). Serum total cholesterol and trig-
lycerides were measured enzymatically, and 
total lipids were calculated by Phillips formula 
(Bernert et al. 2007; Phillips et al. 1989a).
Statistical analysis. We explored the rela-
tionship between IVF outcomes and three 
individual PCB congeners (PCB congeners 
118, 138, and 153), as well as the sum of all 
measured congeners (∑PCBs). In addition, an 
analysis of the relationship between IVF out-
comes and groupings of PCBs was conducted 
based on structural and biological activity, as 
previously proposed (Wolff et al. 1997). PCBs 
were grouped as follows: group 1, potentially 
estrogenic and weak phenobarbitol inducers 
(congeners 44, 49, 52, 101, 187, 174, 177, 
157/201); group 2, potentially antiestrogenic 
and dioxin-like (congeners 95/66, 74, 77/110, 
105/141, 118, 156, 167, 128, 138, 170); and 
group 3, phenobarbital, cytochrome P450 
(CYP)1A, and CYP2B inducers (congeners 
99, 153, 180, 196/203, 183). When forming 
the summed values, congeners with concentra-
tions below the MDL were assigned a value 
of MDL divided by the square root of 2.0. 
Distributions of organochlorine concentra-
tions in serum were tabulated and compared 
between the primary congeners and congener 
groupings of interest.
We used multivariate generalized linear 
regression models to assess the association 
of serum levels of PCB congeners and PCB 
groupings, categorized into quartiles, with 
early pregnancy failure. The data were struc-
tured to accommodate joint models for multi-
ple outcomes and multiple cycles per woman. 
In each cycle, whenever a woman was at risk 
of having a failure due to implantation failure, 
chemical pregnancy, or spontaneous abortion, 
a binary outcome (Y) was recorded (1 = failure, 
0 = not a failure). Thus, a woman could make 
up to three contributions to risk sets for the 
possible outcomes within each IVF cycle. For 
example, if a woman experienced implantation 
failure in cycle 1, and spontaneous abortion 
in cycle 2, but had a live birth in cycle 3, then 
we would consider the woman at risk only for 
implantation failure in the first cycle (her out-
come is failure), at risk for both implantation 
failure and spontaneous abortion in the second 
cycle (she did not fail during the first possible 
failure point and thus continued to be at risk 
for the second possible failure type), and at 
risk for all three failure outcomes for the third 
cycle (but she did not fail at any of these three 
failure points). The correlation among both 
multiple failure types and among cycles for the 
same woman is taken into account by incorpo-
rating a random effect for each woman, which 
adjusts for the correlation between multiple 
outcomes on each woman.
We then used a logistic regression model 
for each early pregnancy outcome while adjust-
ing for other covariates. To account for the 
possibility that the relationship between PCBs 
and different types of failure end point may 
differ, we included interaction terms between 
PCB quartile and failure type in the model. 
Similar interaction terms were also considered 
for age and failure type to explore the possibil-
ity of differing age effects on the various failure 
end points, although these interactions were 
not statistically significant and were removed 
from the final models. To account for depen-
dence between two cycles for a particular 
woman, we included woman-specific random 
effects, which were assumed to be Gaussian. 
Tests for trend were conducted by assigning 
each PCB quartile an ordinal integer value of 
0 (lowest quartile) to 3 (highest quartile).Meeker et al.
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Potential confounding variables consid-
ered in our analysis included those that may 
be associated with serum PCB concentrations 
and/or treatment outcome: serum lipids, site 
(of the three participating Boston-area clin-
ics), study phase (1994–1998 or 1999–2003), 
race/ethnicity (Caucasian vs. other), previous 
live birth (yes/no), maternal age (< 35, 35–37, 
38–40, > 40 years), body mass index (BMI), 
smoking status (never, former, or current), the 
number of ampules of gonadotropins deliv-
ered, ovarian stimulation protocol (down-
regulation vs. other), ICSI (yes/no), number 
of embryos transferred, and primary infertility 
diagnosis (tubal factor, ovulatory dysfunc-
tion, male factor, or unexplained). The use of 
serum levels of lipophilic compounds stan-
dardized by serum lipids (by dividing serum 
concentration of the compound of interest 
by serum lipids) as an independent variable 
in multivariate models has been shown to be 
prone to bias (Schisterman et al. 2005). Thus, 
we also modeled IVF outcomes in relation to 
wet-weight serum levels of PCBs and adjusted 
for serum lipids as a covariate in multivari-
ate models, as recommended by Schisterman 
et al. (2005) because of the lower bias of this 
approach in most scenarios. Because many 
studies report PCB effect estimates based on 
lipid-standardized concentrations, we also 
used lipid-standardized concentrations as the 
exposure variable in the models for compari-
son in a secondary analysis.
Data analysis was conducted using SAS 
software (Version 9.1; SAS Institute Inc., 
Cary, NC). p-Values < 0.05 were considered 
statistically significant.
Results
Data on a total of 827 IVF or ICSI cycles 
from 765 women were included in our anal-
ysis (Table 1). The women had a mean age 
of 35.9 years and were primarily Caucasian 
(91%) nonsmokers (92%). Almost one-quar-
ter of the women (24%) had a previous live 
birth. Approximately two-thirds of the women 
had either unexplained infertility (34%) or 
were in couples diagnosed with male factor 
infertility (35%), and the remaining one-third 
of women were diagnosed with either tubal 
factors (19%) or ovulatory dysfunction (13%). 
Distributions of serum PCB concentrations 
are presented as both wet weight (nanograms 
per gram serum) and as lipid-standardized 
concentrations (nanograms per gram lipid) 
in Table 2. As expected, PCB-153 was the 
congener present in the highest concentration 
(median = 46.2 ng/g lipid; range 4.0–428 ng/g 
lipid) and, on average, accounted for 18% 
of ∑PCBs. There were strong correlations 
between the three primary congeners of inter-
est, the three congener groupings, and ∑PCBs. 
Spearman correlation coefficients ranged from 
0.62 between PCB-118 and group 1 conge-
ners to 0.95 between PCB-153 and group 3 
congeners (data not shown).
Table 3 presents adjusted odds ratios 
(ORs) for failed implantation, chemical preg-
nancies, and spontaneous abortions in relation 
to PCB quartiles. Because of missing data for 
certain covariates, 774 cycles from 720 women 
contributed to the multivariate analysis (see 
Table 3 footnote). PCB-153 and ∑PCBs were 
associated with significantly elevated odds 
of failed implantation, and these relation-
ships demonstrated dose-  dependent trends. 
The second through the fourth quartiles were 
associated with ORs [95% confidence inter-
vals (CIs)] of 1.1 (0.7–1.9), 1.3 (0.8–2.2), 
and 1.7 (1.0–2.9; p-value for trend = 0.03) 
for ∑PCBs and 1.6 (1.0–2.7), 1.6 (1.0–2.7), 
and 2.0 (1.2–3.4; p-value for trend = 0.02) for 
PCB-153, compared with the lowest quartile. 
There were suggestive trends for increased 
odds of implantation failure for PCB-118 
(p-value for trend = 0.06) and group 3 con-
geners (p-value for trend = 0.06), but ORs did 
not follow monotonic dose–response patterns. 
None of the congeners or congener group-
ings were significantly associated with odds of 
chemical pregnancy or spontaneous abortion.
As a potentially more clinically relevant 
measure of effect, we also calculated the odds of 
a live birth in relation to serum PCB quartiles 
(Table 4). Quartiles of PCB-153 again fol-
lowed a dose-related trend, where the odds 
of live birth were reduced by 12%, 35%, and 
41% in quartiles 2–4, respectively, compared 
with the lowest PCB-153 quartile (p-value for 
trend = 0.03). The third and fourth ∑PCB 
quartiles were also associated with 41% reduc-
tions in the odds of a live birth (p-value for 
trend = 0.02). Reductions in the odds of live 
birth were observed for PCB-118 and for 
group 2 and group 3 congeners, but these rela-
tionships were not statistically significant.
Because many studies standardize PCB 
concentrations for lipid content before ana-
lyzing the data, we conducted a secondary 
analysis using lipid-standardized values in the 
models. Overall results were similar to those 
presented [see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002922)]. The primary dif-
ferences were that the associations for PCB-118 
and group 3 congeners with failed implanta-
tion and live birth became slightly stronger, 
whereas the relationships between ∑PCBs and 
these outcomes were slightly weakened.
Discussion
In our study we report that serum concentra-
tions of PCBs in women may be associated 
with adverse IVF/ICSI outcomes. In particular, 
Table 1. Distribution of demographic, covariate, 
and outcome data.a
Characteristic Value
Age (years)  35.9 ± 4.21
BMI 24.2 ± 5.09
Caucasian  693 (90.6)
Current smoker  50 (6.5)
Former smoker  223 (29.2)
Previous live birth 181 (23.6)
Ampules of gonadotropinsb 34.4 ± 18.0
Protocol (downregulation) b,c  604 (73.1)
ICSI procedure (yes)b  259 (31.3)
No. of embryos transferredb 3.15 ± 1.33
Lipids (mg/dL)d 512 ± 113
Cholesterol  162 ± 35.7
Triglycerides  93.6 ± 55.5
Infertility diagnosis 
Tubal factor 143 (18.7)
Ovulatory dysfunction 99 (12.9)
Male factor 267 (34.9)
Unexplained 256 (33.5)
IVF/ICSI outcomesb 
Failed implantation 229 (27.7)
Chemical pregnancye 177 (21.4)
Spontaneous abortion 124 (15.0)
Other (ectopic/stillbirth) 11 (1.33)
Live birth 286 (34.6)
Values are mean ± SD or n (%).
an = 765 women, 827 cycles. bCalculated from cycle-level 
data. cOvarian stimulation protocol, coded as down-
regulation versus other (antagonist or flare). dTotal lipids 
calculated from cholesterol and triglycerides using the 
Philips formula (Bernert et al. 2007; Phillips et al. 1989a). 
eChemical pregnancy: defined as a luteal hCG meas-
urement of ≥ 5.0 mIU/mL with no further evidence (gesta-
tional sac and fetal heartbeat) of a continued pregnancy.
Table 2. Distribution of serum PCB concentrations among 765 women undergoing IVF/ICSI.
PCB congener or grouping Geometric mean Minimum First quartile Median Third quartile Maximum
Wet weight (ng/g serum)
PCB-118 0.083 0.014 0.052 0.080 0.123 1.34
PCB-138 0.14 0.013 0.090 0.138 0.202 1.12
PCB-153 0.23 0.015 0.16 0.24 0.34 2.33
Group 1 PCBs 0.099 0.020 0.072 0.099 0.135 0.93
Group 2 PCBs 0.44 0.098 0.296 0.434 0.619 3.62
Group 3 PCBs 0.49 0.041 0.35 0.51 0.74 5.04
∑PCB 1.32 0.32 0.95 1.32 1.81 10.3
Lipid standardized (ng/g lipid)
PCB-118 16.6 2.80 10.5 16.0 24.7 271
PCB-138 27.3 2.71 17.7 27.5 41.5 226
PCB-153 45.4 4.03 30.4 46.2 70.1 428
Group 1 PCBs 19.7 4.07 14.2 20.0 26.9 171
Group 2 PCBs 86.8 13.1 58.0 86.3 124 766
Group 3 PCBs 97.6 8.16 65.3 101.2 150 927
∑PCB 257 41.0 182 259 367 1,887PCBs and IVF outcomes
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 7 | July 2011  1013
we found that the odds of failed implantation 
were doubled, and the odds of a live birth were 
reduced by 41%, among women in the high-
est serum PCB-153 quartile compared with 
women in the lowest PCB-153 quartile. Serum 
∑PCBs, which was strongly correlated with 
PCB-153, was also associated with implanta-
tion failure and reduced odds of a live birth.
As far as we are aware, this is the first 
human study to assess the relationship between 
PCB exposure and failed implantation, 
although two small studies have assessed the 
relationship between PCBs in follicular fluid 
and other IVF outcomes (e.g., fertilization 
rate) (Jirsova et al. 2010; Younglai et al. 2002). 
Because implantation failure is common and 
occurs before a pregnancy is recognized among 
couples conceiving spontaneously (Chard 
1991; Norwitz et al. 2001), our findings may 
be comparable with those in epidemiologic 
studies of PCB exposure and time to pregnancy 
(TTP). However, TTP as an outcome lacks 
specificity, because it may represent one or 
more aspects of female or male factors. Several 
studies have reported an association between 
PCB exposure and increased TTP. A study of 
186 women exposed to high concentrations of 
PCBs in the 1978–1979 Taiwanese cooking 
oil contamination incident reported a fecund-
ability ratio of 0.90 (95% CI, 0.80–1.00) com-
pared with a group of 226 reference women 
(Yang et al. 2008). The Collaborative Perinatal 
Project, which included 390 U.S. women who 
were pregnant between 1959 and 1965, also 
reported a reduced fecundability odds ratio 
(FOR) of 0.65 (95% CI, 0.36–1.18) among 
women in the highest serum ∑PCB category 
(> 5 µg/L) compared with women in the lowest 
exposure category (Law et al. 2005). In the first 
human study to assess preconception serum 
PCB concentrations and TTP, Buck Louis 
et al. (2009) reported FORs of 0.32 (95% CI, 
0.03–3.89) and 0.01 (< 0.00–1.99) for estro-
genic and antiestrogenic PCB congener group-
ings, respectively, among a subset of 81 women 
planning pregnancies who were followed for a 
total of 444 menstrual cycles in the New York 
State Angler Cohort Study. A number of ear-
lier studies examined organochlorine exposure 
through consumption of contaminated fish 
in relation to TTP, with conflicting results 
(Arakawa et al. 2006; Axmon et al. 2000b, 
2001, 2002, 2004, 2006; Buck et al. 2000). 
Limitations in many of these studies include 
the use of exposure surrogates instead of 
exposure biomarkers, self-recall of TTP, and 
the inclusion of only women who achieved 
clinical pregnancy or whose pregnancies 
resulted in a live birth. Our observation of a 
relationship between PCBs and failed implan-
tation is consistent with the more recent and 
rigorously designed TTP studies showing 
Table 3. Adjusted ORsa for IVF/ICSI failures in relation to serum PCB quartiles (Q) among cycles with an 
embryo transfer.b
No. of 
cycles
No. of 
women
Failed implantation Chemical pregnancy Spontaneous abortion
Exposure 
quartiles
No. of 
events ORs (95% CI)
No. of 
events ORs (95% CI)
No. of 
events ORs (95% CI)
PCB-118
Q1 196 185 43 Referent 54 Referent 25 Referent
Q2 196 183 59 1.81 (1.11–2.97) 38 0.72 (0.43–1.22) 34 1.50 (0.79–2.83)
Q3 190 176 71 2.34 (1.42–3.84) 38 0.89 (0.52–1.51) 33 1.70 (0.87–3.32)
Q4 192 185 61 1.60 (0.96–2.69) 47 0.91 (0.54–1.53) 41 1.29 (0.66–2.53)
p for trend 0.06 0.87 0.42
PCB-138
Q1 197 184 49 Referent 45 Referent 31 Referent
Q2 198 189 59 1.42 (0.87–2.30) 41 0.98 (0.58–1.68) 25 0.68 (0.36–1.34)
Q3 185 170 62 1.51 (0.91–2.48) 46 1.18 (0.68–2.05) 30 1.10 (0.57–2.15)
Q4 194 190 64 1.39 (0.83–2.30) 45 1.10 (0.63–1.91) 38 1.14 (0.59–2.20)
p for trend 0.24 0.61 0.41
PCB-153
Q1 197 188 46 Referent 45 Referent 30 Referent
Q2 193 182 57 1.63 (0.99–2.71) 42 1.04 (0.60–1.78) 26 0.89 (0.46–1.73)
Q3 192 179 59 1.59 (0.95–2.66) 46 1.09 (0.63–1.90) 33 1.18 (0.61–2.27)
Q4 192 186 72 1.99 (1.16–3.40) 44 1.17 (0.66–2.10) 35 1.13 (0.56–2.27)
p for trend 0.02 0.58 0.56
Group 1 PCBs
Q1 195 186 59 Referent 41 Referent 28 Referent
Q2 194 187 50 0.87 (0.54–1.41) 46 1.06 (0.63–1.80) 34 1.20 (0.64–2.26)
Q3 195 187 57 0.99 (0.61–1.61) 44 0.97 (0.56–1.68) 30 0.83 (0.43–1.62)
Q4 190 183 68 1.19 (0.72–1.93) 46 1.13 (0.65–1.98) 32 0.93 (0.46–1.85)
p for trend 0.38 0.76 0.59
Group 2 PCBs
Q1 196 185 51 Referent 46 Referent 27 Referent
Q2 197 187 56 1.27 (0.78–2.08) 41 0.91 (0.53–1.55) 27 0.91 (0.47–1.76)
Q3 191 178 60 1.44 (0.87–2.36) 41 0.97 (0.56–1.68) 39 1.66 (0.86–3.18)
Q4 190 184 67 1.38 (0.82–2.32) 49 1.17 (0.67–2.05) 31 1.07 (0.53–2.14)
p for trend 0.20 0.54 0.44
Group 3 PCBs
Q1 198 189 46 Referent 45 Referent 30 Referent
Q2 191 180 57 1.44 (0.88–2.38) 39 0.90 (0.53–1.55) 30 1.01 (0.53–1.93)
Q3 193 178 59 1.42 (0.85–2.38) 51 1.26 (0.74–2.17) 27 0.94 (0.48–1.85)
Q4 192 187 71 1.75 (1.03–2.97) 42 1.02 (0.57–1.84) 37 1.13 (0.57–2.25)
p for trend 0.05 0.65 0.79
∑PCB
Q1 197 187 46 Referent 42 Referent 28 Referent
Q2 194 186 52 1.13 (0.68–1.85) 43 1.08 (0.69–1.85) 33 1.19 (0.63–2.26)
Q3 193 182 58 1.33 (0.81–2.18) 48 1.34 (0.78–2.31) 32 1.36 (0.70–2.65)
Q4 190 184 73 1.70 (1.02–2.85) 44 1.27 (0.71–2.29) 31 1.07 (0.53–2.15)
p for trend 0.03 0.30 0.75
aJoint models for multiple outcomes and multiple cycles per woman were used. Models were adjusted for serum lipids, 
study site, study phase, race/ethnicity, previous live birth, maternal age, BMI, smoking status, ampules of gonadotropins, 
protocol, ICSI, number of embryos transferred, and primary infertility diagnosis. bThere were 827 cycles with serum sam-
ples analyzed for PCB concentrations. However, because of missing covariates, only 774 cycles from 720 women contrib-
uted to the multivariate analysis. Missing ethnicity, infertility diagnosis, and previous live birth were recoded as a separate 
category so that cycles missing this information were in the multivariate models. If a cycle was missing any other covari-
ate, that cycle was dropped from the multivariate analysis. Specifically, 13 cycles were missing lipids, 2 cycles were miss-
ing ampules of gonadotropins, 32 cycles were missing number of embryos transferred, and 6 cycles were missing BMI.
Table 4. Adjusted ORs (95% CIs)a for live birth in relation to serum PCB quartiles (Q) among cycles with an embryo transfer.b
Exposure quartiles PCB-118 PCB-138 PCB-153 Group 1 PCBs Group 2 PCBs Group 3 PCBs ∑PCB
Q1 Referent Referent Referent Referent Referent Referent Referent
Q2 0.73 (0.48–1.11) 0.95 (0.62–1.45) 0.88 (0.56–1.37) 0.91 (0.59–1.42) 0.87 (0.57–1.35) 0.89 (0.57–1.39) 0.75 (0.49–1.16)
Q3 0.51 (0.32–0.81) 0.68 (0.42–1.07) 0.65 (0.41–1.05) 0.97 (0.61–1.52) 0.59 (0.37–0.94) 0.69 (0.43–1.12) 0.59 (0.37–0.94)
Q4 0.74 (0.47–1.15) 0.73 (0.45–1.16) 0.59 (0.35–1.00) 0.79 (0.49–1.26) 0.68 (0.42–1.11) 0.67 (0.44–1.13) 0.59 (0.35–0.98)
p for trend 0.09 0.57 0.03 0.40 0.05 0.08 0.02
aJoint models for multiple outcomes and multiple cycles per woman were used. Models were adjusted for serum lipids, study site, study phase, race/ethnicity, previous live birth, 
maternal age, BMI, smoking status, ampules of gonadotropins, protocol, ICSI, number of embryos transferred, and primary infertility diagnosis. bn = 720 women, 744 cycles.Meeker et al.
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an inverse relationship between PCBs and 
fecundability. Although the women in those 
studies had serum PCB concentrations that 
were much higher than the women in our 
study, our findings add to those studies by 
providing insight into a specific aspect and 
time point within early postconception that 
contributes to TTP and may be particularly 
sensitive to PCB exposure.
In this study, the lack of association 
between PCBs and risk of spontaneous abor-
tion was consistent with a recent study of 
1,344 pregnancies in Michigan women that 
reported no association between serum PCB 
concentrations > 5 ng/g wet weight and risk 
of miscarriage (Small et al. 2007) but was 
inconsistent with a recent European study 
of 1,710 women that reported an associa-
tion between PCB-153 at serum concen-
trations of > 200 ng/g lipid and increased 
risk of fetal loss (miscarriages or stillbirths) 
(Toft et al. 2010). Several earlier studies also 
reported evidence for a relationship between 
PCBs and miscarriage (Bercovici et al. 1983; 
Leoni et al. 1989; Tsukimori et al. 2008), 
whereas other earlier studies reported no asso-
ciations (Axmon et al. 2000a; Dar et al. 1992; 
Khanjani and Sim 2007; Mendola et al. 1995; 
Sugiura-Ogasawara et al. 2003). Many of the 
early studies were limited by small sample 
sizes or indirect exposure assessments (e.g., 
consumption of contaminated fish). In addi-
tion, study designs and PCB exposure levels 
between studies have differed greatly. Our 
data do not support the presence of an asso-
ciation between PCBs at levels similar to 
those among the general population and fetal 
loss. However, the overall body of evidence 
remains inconsistent, and the generalizability 
of our findings to highly exposed populations 
or women not undergoing assisted reproduc-
tion are unknown, so this relationship may 
require further inquiry.
Our observation of an association between 
PCB exposure and implantation failure 
is consistent with studies from the experi-
mental literature, many of which were con-
ducted with low and environmentally relevant 
dose levels (ATSDR 2000). Animal studies 
have demonstrated that PCBs cause reduced 
oocyte maturation (reviewed by Pocar et al. 
2006), increased embryo degeneration and 
decreased embryo cell proliferation, blastocyst 
formation and blastocyst development, and 
decreased IVF success rates (Campagna et al. 
2001, 2002; Kholkute and Dukelow 1997; 
Kholkute et al. 1994a, 1994b; Krogenaes 
et al. 1998; Kuchenhoff et al. 1999; Lindenau 
and Fischer 1996; Pocar et al. 2001), along 
with increased implantation failures (Linder 
et al. 1974), increased resorptions (Arnold 
et al. 1995), and decreased litter produc-
tion (Jonsson et al. 1975; Seiler et al. 1994). 
PCB impacts on uterine receptivity may also 
contribute to an increased risk of implan-
tation failure. For example, consistent with 
animal research (ATSDR 2000), some epi-
demiologic studies have reported associations 
between PCB exposure and altered menstrual 
cycles (Chao et al. 2007; Cooper et al. 2005; 
Mendola et al. 1997; Toft et al. 2004, 2008; 
Yu et al. 2000) and endometriosis (Anger 
and Foster 2008; Gerhard et al. 1999; Heilier 
et al. 2008; Porpora et al. 2006, 2009).
Our study has a number of strengths. 
First, it was a prospective study with exposure 
biomarkers and outcome measures collected 
at or near the likely time window of inter-
est, which represents an improvement over 
many of the previous studies of PCBs and 
fertility or pregnancy outcomes that relied 
on retrospective study designs. For example, 
some previous studies have used exposure sur-
rogate measures, such as self-reported con-
taminated fish intake, which may introduce 
more exposure measurement error than the 
use of exposure biomarkers. This study used 
detailed, clinically assessed data on outcome 
measures, whereas many previous studies 
relied on participant recall and may have been 
susceptible to recall bias. Second, we were 
able to assess early end points that are impos-
sible or difficult to observe in conventional 
epidemiologic studies. Third, this study was 
large and used outcome data from repeated 
IVF cycles, which resulted in good statistical 
power to detect associations between serum 
PCB concentrations and failed implantation, 
chemical pregnancies, and spontaneous abor-
tions. Finally, most previous studies have been 
conducted among populations with elevated 
PCB exposures, whereas women in our study 
had serum PCB concentrations that are more 
representative of the general population. For 
example, median (75th percentile) PCB-153 
concentrations in serum samples collected 
between 1994 and 2003 in this study 
were 46 (70) ng/g lipid compared with 35 
(63) ng/g lipid and 24 (47) ng/g lipid among 
adults ≥ 20 years of age from the National 
Health and Nutrition Examination Survey 
(NHANES) 2001–2002 and NHANES 
2003–2004, respectively (Centers for Disease 
Control and Prevention 2009).
Our study also has a number of limita-
tions. First, as with nearly all environmental 
epidemiologic studies, there may be unmea-
sured confounding or coexposures that may 
explain the observed associations. For exam-
ple, if fish consumption is the primary source 
of PCB-153, it is possible that other expo-
sures or activities related to fish consumption 
are confounding the relationship of PCB-153 
with failed implantation. Second, because our 
study was conducted among women undergo-
ing IVF, the extent to which we can general-
ize our findings to wider populations is not 
clear. For our results to lack generalizability, 
women undergoing IVF would have to dif-
ferentially respond to PCB exposure com-
pared with women conceiving spontaneously. 
There is currently no evidence suggesting 
these women may be more susceptible to PCB 
exposure, although it is possible that PCB 
exposure may contribute to a couple’s fecund-
ability and need for IVF treatment. However, 
even if women undergoing IVF represent a 
subgroup particularly sensitive to PCBs, our 
findings could have important implications, 
because couples seeking fertility treatment 
represent a large and growing proportion of 
the population. Nevertheless, the consistency 
between our findings and human TTP studies 
suggests that our results may be generalizable. 
In addition, because our results are consistent 
with animal studies, they may provide further 
evidence that couples undergoing IVF pro-
vide a unique opportunity to study detailed 
reproductive end points not normally observ-
able in humans. Another limitation of the 
present analysis is that we did not include 
earlier measures that are observable in couples 
undergoing IVF, such as oocyte quality, failed 
fertilization, and embryo quality. Because ani-
mal studies suggest that these end points may 
also be adversely affected by PCBs, these out-
comes should be assessed in relation to serum 
PCB concentrations in the future. Studies that 
assess more detailed outcome measures may 
also provide additional clues for the potential 
mechanisms of action involved in the relation-
ships reported here, which currently remain 
unclear. Finally, we did not have exposure 
data on male partners. There have been sev-
eral reports of an association between PCB 
exposure and reduced semen quality (Meeker 
and Hauser 2010), which may also contribute 
to increased TTP and poor embryo quality in 
relation to PCB exposure.
In conclusion, we found that serum PCB 
concentrations representative of those meas-
ured among the U.S. general population 
were associated with increased odds of failed 
implantation among women undergoing IVF. 
These findings may help explain previous 
reports of reduced fecundability and increased 
TTP among women exposed to PCBs.
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